Survodutide 10mg

DRAGON PHARMA SURVODUTIDE

Survodutide 10 mg, developed by Dragon Pharma, is a potent dual-action GLP-1 receptor agonist and glucagon receptor agonist designed to promote fat loss and improve metabolic function. Each 2 mL vial contains 10 mg of Survodutide, a compound that enhances energy expenditure and helps regulate appetite, making it ideal for athletes and bodybuilders seeking effective weight management during cutting phases. By activating key metabolic pathways, Survodutide aids in fat reduction while maintaining lean muscle mass.

DRUG COMPOSITION

Active substance: Survodutide (10 mg per vial)
Excipients: Sterile water and preservatives for injection stability.

LAB TEST REPORT

PHARMACEUTICAL FORM

Survodutide is provided as a lyophilized powder, reconstituted with bacteriostatic water for subcutaneous or intramuscular injection.

PHARMACEUTICAL GROUP AND ATC CODE

Pharmaceutical Group: Antidiabetic agent, Anti-obesity agent
ATC Code: A10BJ06 (Glucagon-like peptide-1 receptor agonists)

PHARMACOLOGICAL PROPERTIES

Survodutide works as a dual GLP-1 and glucagon receptor agonist, promoting fat loss by enhancing energy expenditure and regulating glucose metabolism. It helps control blood sugar levels, curb appetite, and increase fat oxidation, making it highly effective for athletes and bodybuilders aiming to reduce body fat while maintaining muscle mass.

PROFILE

• Chemical name: Survodutide (BI 456906)
• Chemical formula: C192H289N47O61
• Percentage of anabolic activity: None
• Percentage of androgenic activity: None
• Active half life: Approximately 5-7 days
• Recommended dosage: Under clinical investigation; weight loss trials suggest once-weekly administration
• Acne: None
• Bloating (water retention): Unlikely
• HBR: Unlikely
• Hepatic toxicity: Low
• Aromatization: None

THERAPEUTICAL INDICATIONS

Survodutide 10 mg is indicated for athletes and bodybuilders focused on fat loss, metabolic improvement, and body recomposition. It is also used to manage obesity and improve weight control, particularly during cutting cycles or competitive prep phases.

DOSES AND METHOD OF ADMINISTRATION

The typical dosage of Survodutide for athletes and bodybuilders is 10 mg weekly. It is administered subcutaneously or intramuscularly and should be injected at the same time each week to ensure consistent metabolic benefits. Adjustments in dosage may be necessary based on individual response.

CYCLE/STACKING

Survodutide can be stacked with other Dragon Pharma products to enhance fat loss and muscle retention during cutting or recomposition phases. Here are some example cycles:

• Cutting Cycle (8-12 weeks):

  • Survodutide 10 mg: Once per week
  • Stack with Winstrol (Stanozolol) 50 mg per day to preserve lean muscle mass while cutting fat.
  • Add Clenbuterol for enhanced fat loss and thermogenic effects.

• Recomposition Cycle (8-12 weeks):

  • Survodutide 10 mg: Once per week
  • Stack with Enanthate 250 (Testosterone Enanthate) 300 mg per week to build lean muscle while losing fat.
  • Combine with Anavar to further increase muscle definition and fat reduction.

POST CYCLE THERAPY

Survodutide does not affect natural testosterone levels, so PCT is not required when used alone. However, if used in combination with anabolic steroids, follow a standard PCT regimen with Clomid or Nolvadex to restore natural hormone levels.

SIDE EFFECTS

Survodutide is generally well tolerated. Possible side effects include mild gastrointestinal discomfort, nausea, and appetite changes, which typically subside as the body adjusts. Severe side effects are rare, but if they occur, discontinue use and consult a healthcare provider.

CONTRAINDICATIONS

Survodutide is contraindicated in individuals with severe liver or kidney diseases, active thyroid cancer, or a known hypersensitivity to GLP-1 receptor agonists. It should not be used by pregnant or breastfeeding women.

OVERDOSE

In case of overdose, symptoms may include severe nausea, vomiting, or rapid weight loss. Seek immediate medical attention if overdose is suspected.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE:

Athletes using Survodutide should monitor blood sugar levels, especially if they have a history of diabetes or hypoglycemia. It should be used responsibly under medical supervision for those with pre-existing metabolic disorders.

INTERACTIONS WITH OTHER DRUGS

Survodutide may interact with insulin or other glucose-lowering medications. Always consult with a healthcare provider before combining with other medications or performance-enhancing substances.

PRESENTATION, PACKAGING

Survodutide by Dragon Pharma is packaged in 2 mL vials containing 10 mg of lyophilized Survodutide. The packaging ensures safe and discreet delivery.

STORAGE

Store in a cool, dry place away from direct sunlight. Once reconstituted, refrigerate and use within 30 days. Keep out of reach of children.

DELIVERY TO THE USA

We offer fast, secure, and discreet delivery of Dragon Pharma's Survodutide 10 mg to the USA. Orders are carefully packaged to ensure safe arrival at your doorstep.

LEGAL STATUS

Survodutide is available for research and off-label use in many countries, including the USA. It is not FDA-approved for medical use, so check your local regulations before purchasing.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Dragon Pharma
Europe

EXTERNAL LINKS

• Survodutide, the New England Journal of Medicine, nejm.org